Skip to content
Aster DM Healthcare logo

Aster DM Healthcare

Aster DM Quality Care Ltd

ASTERDM NSE
₹779.30 +40.00 (+5.41%)
Market Cap
₹67,929 Cr
P/E
110.70
View as Markdown
MCP
Close 20 Nov 2026 ₹779.30 1Y +111.45 +16.7%
Start ₹667.85

Key Fundamentals

MidcapHealthcare ServicesHealthcare

Price-based figures as of · EPS basis: Consolidated · TTM

ROCE
11.60%
Debt to Equity
0.76
EPS (TTM)
₹7.04
Book Value
₹89.38
Market Cap
₹67,929 Cr
P/E (TTM)
110.70
P/B
8.72
ROE
11.30%
Dividend Yield
0.41%
EBITDA
₹1,027 Cr
52W High
₹891.30
52W Low
₹519.10
Day Range
₹729.00 – ₹781.85
Volume
26,65,994

Peer Comparison

Healthcare › Healthcare Services › Hospital

Aster DM Healthcare peer comparison
9,200.0059.001,32,28212.470.23%21.50%17.40%27,6302,337
1,081.0076.231,05,2159.280.20%14.70%14.70%9,1461,380
702.20101.7792,3666.010.00%6.72%8.30%12,370873
Aster DM Healthcare (this company)
779.30110.7067,9298.720.41%11.30%11.60%6,508564
825.0059.9662,2845.940.13%11.20%13.40%9,9101,061
1,480.2064.3339,7989.200.03%15.20%17.40%5,053613
1,943.7046.2539,7227.940.24%20.50%15.50%10,273859
Median 7 companies1,081.0064.3367,9298.720.20%14.70%14.70%9,910873

Comparable companies in the same industry. Market cap, P/E and P/B use the latest price; other metrics are as reported in filings. A dash means the figure is not published for that company.

Tapetide Score

Data-driven rating, 0–100, as of . How it works →

Overall score

43 Weak

Data confidence 100/100

pledge:67%

Category scores

Quality
30
Poor
Returns, margins, earnings quality 22% weight
Valuation
35
Poor
Cheap vs sector & own history 24% weight
Growth
99
Strong
Sales & profit trajectory 9% weight
Financial Health
33
Poor
Solvency, leverage, coverage 9% weight
Momentum
18
Poor
Trend strength, vol-adjusted 12% weight
Ownership
96
Strong
FII/DII/promoter flows 24% weight

The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.

Key Insights

Strengths

3
  • Company is expected to give good quarter
  • Company has been maintaining a healthy dividend payout of 1,560%
  • Promoter holding has increased by 13.4% over last quarter.

Weaknesses

4
  • Stock is trading at 8.72 times its book value
  • Company has a low return on equity of 8.46% over last 3 years.
  • Company might be capitalizing the interest cost
  • Promoters have pledged 67.0% of their holding.

Technical Indicators

Technical signals: verdict and indicator counts
GroupSignalBearishNeutralBullish
OverallStrong Bullish2512
OscillatorsNeutral252
Moving AveragesStrong Bullish0010

Key readings

RSI (14)
65.83
Neutral
MACD (12,26,9)
14.24
Bullish
SMA (50)
713.85
Bullish
SMA (200)
724.74
Bullish

As of

Analyst Rating

Based on 12 analysts
BUY100%

12 of 12 analysts rate Buy, 0 Hold, 0 Sell.

As of

BUY
12
100%
HOLD
0
0%
SELL
0
0%

Growth Rate

From the financial statements below. 10Y, 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025; TTM: four quarters to Sep 2026 against Sep 2025.

Revenue

Revenue growth by window
10Y−1.22%
5Y−11.61%
3Y+15.75%
1Y+12.20%
TTM+50.47%

Net profit

Net profit growth by window
10Y+48.84%
5Y+19.12%
3Y−3.49%
1Y−92.10%
TTM+54.52%

Operating cash flow

Operating cash flow growth by window
10Y+12.45%
5Y−16.00%
3Y−29.01%
1Y+54.35%
TTM—

TTM: Reported once a year, so there is no trailing-twelve-month figure.

Operating margin· change in pp

Operating margin growth by window
10Y+10.37 pp
5Y+6.04 pp
3Y+3.92 pp
1Y+0.58 pp
TTM+1.90 pp

Revenue by year

Revenue by year, ₹ crore
Mar 2017₹5,931 Cr
Mar 2018₹6,721 Cr
Mar 2019₹7,963 Cr
Mar 2020₹8,652 Cr
Mar 2021₹8,608 Cr
Mar 2022₹10,253 Cr
Mar 2023₹2,994 Cr
Mar 2024₹3,699 Cr
Mar 2025₹4,138 Cr
Mar 2026₹4,643 Cr

Net profit by year

Net profit by year, ₹ crore
Mar 2017₹98.00 Cr
Mar 2018₹282 Cr
Mar 2019₹367 Cr
Mar 2020₹315 Cr
Mar 2021₹178 Cr
Mar 2022₹601 Cr
Mar 2023₹475 Cr
Mar 2024₹212 Cr
Mar 2025₹5,408 Cr
Mar 2026₹427 Cr

Analyst Forecasts

Forecast For
Dec 26 consensus · EBITDA
₹618 Cr −10.2% vs Sep 26
Reported High Mean Low

AI Analysis — Bull vs Bear

Figures as of 19 Nov 2026
AI opinion · based on fundamentals
Risk high

Aster DM Healthcare trades at ₹739.3 as of 2026-11-19 with a market cap of ₹64,443 Cr. The stock commands a PE of 105x TTM earnings and 8.66x book value, reflecting premium valuations, while TTM sales growth of 50% and profit growth of 43% show a strong recent rebound. However, a 3-year profit CAGR of -1% and promoter pledge of 67% introduce meaningful risk factors.

Bull Case 8
  • TTM revenue growth of 50% signals a sharp acceleration in the top line, well above the 3-year sales CAGR of 16%
  • TTM profit growth of 43% demonstrates a strong earnings recovery after a flat 3-year profit CAGR of -1%
  • Promoter holding increased by 13.4% over the last quarter, indicating meaningful insider confidence at current levels
  • 5-year stock CAGR of 30% and 3-year stock CAGR of 30% reflect sustained long-term wealth creation for shareholders
  • 10-year compounded profit growth of 48% highlights a strong long-term earnings trajectory despite interim volatility
  • Debt-to-equity ratio of 0.62 is moderate and manageable for a capital-intensive healthcare business
  • The company has maintained a healthy dividend payout of 1,560%, returning significant capital to shareholders
  • Last year ROE of 11% shows improvement over the 3-year average ROE of 8% and 10-year average of 9%
Bear Case 7
  • Promoters have pledged 67.0% of their holding, creating significant risk of forced selling in a downturn
  • Price-to-book of 8.66x is steep and well above typical healthcare sector averages, pricing in aggressive future expectations
  • 3-year compounded profit growth of -1% indicates earnings stagnated over a meaningful medium-term window
  • 5-year compounded sales growth of -12% reflects a period of significant revenue contraction, likely tied to the GCC divestment
  • 3-year average ROE of approximately 8% and current ROE of 8.84% are modest for a stock trading at such premium valuations
  • ROCE of 9.71% suggests the business earns only a thin spread over its cost of capital, questioning the premium multiple
  • The stock trades 17% below its 52-week high of ₹891.3 but 42% above its 52-week low of ₹519.1, suggesting volatility risk persists

This is AI-generated analysis, not financial advice. Do your own due diligence.

AI News Digest

22h ago

TL;DR: A quiet period for Aster DM with only housekeeping corporate actions — a loan-to-equity conversion in a subsidiary, a board appointment, and post-merger fractional share settlements. No material positive catalysts or red flags emerged. The ₹102.46 Cr equity conversion in Sri Sainatha signals continued commitment to its subsidiary but carries no immediate P&L impact. Investors should watch for upcoming quarterly results and operational updates for directional cues.

Neutral 3
  • ₹102 Cr loan converted to equity Nov 06

    Board approved conversion of ₹102.46 Cr intercompany loan to subsidiary Sri Sainatha into equity and terminated agreements with DMERF.

  • Independent director appointment sought Nov 12

    Postal ballot issued to approve Neela Bhattacharjee as Non-Executive Independent Director for a three-year term ending September 2029.

  • Fractional share payouts certified Nov 09

    Audit Committee certified distribution of net sale proceeds from consolidated fractional shares to eligible shareholders of Quality Care India Limited post-amalgamation.

Quarterly Results

₹ Cr
ASTERDM quarterly results, ₹ crore
Particulars Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Sales
929
955
974
1,002
1,086
1,050
1,000
1,078
1,197
1,186
1,182
1,311
2,829
Expenses
787
805
817
841
869
864
818
876
961
983
958
1,055
2,174
Operating Profit
142
149
156
161
217
186
182
202
236
202
224
256
655
OPM %
15%
16%
16%
16%
20%
18%
18%
19%
20%
17%
19%
20%
23%
Other Income
−64
153
−40
5,120
35
32.99
31.28
29
28
0
37
37.03
51.53
Interest
30
25
30
29
31
31
32
31
31
31
30
31
119
Depreciation
54
57
58
60
62
62
64
63
66
68
67
69
150
Exceptional Items
—
—
—
—
—
−23.72
−26.42
—
—
—
—
−114
−18.95
PBT
−7
220
28
5,191
159
102
91
136
167
103
163
78
419
Tax %
120%
5%
108%
1%
33%
37%
6%
31%
27%
43%
6%
62%
23%
Net Profit
−15
209
−2
5,152
106
64
86
94
121
59
154
29
322
EPS (₹)
−0.62
3.59
−0.48
103.00
1.94
1.14
1.58
1.65
2.12
1.01
2.71
0.31
3.01
YoY Sales growth
−67
−70
21
19
17
10
3
8
10
13
18
22
136

Profit & Loss

₹ Cr
ASTERDM profit and loss, annual, ₹ crore
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
3,876
5,250
5,931
6,721
7,963
8,652
8,608
10,253
2,994
3,699
4,138
4,643
6,508
Expenses
3,370
4,805
5,582
6,089
6,886
7,187
7,506
8,720
2,547
3,124
3,383
3,769
5,170
Operating Profit
506
445
349
632
1,077
1,465
1,103
1,533
447
575
756
875
1,338
OPM %
13%
8%
6%
9%
14%
17%
13%
15%
15%
16%
18%
19%
21%
Other Income
23
25
453
177
−155
−158
53
51
353
32
5,168
91
−9
Interest
79
189
371
204
205
391
334
307
96
119
133
132
212
Depreciation
144
243
322
298
306
586
618
641
192
220
249
264
354
PBT
306
38
108
305
410
330
205
636
511
268
5,542
570
764
Tax %
11%
78%
10%
8%
10%
5%
13%
6%
7%
21%
2%
25%
—
Net Profit
272
8
98
282
367
315
178
601
475
212
5,408
427
564
EPS (₹)
5.83
0.18
2.18
5.32
6.59
5.54
2.96
10.53
8.51
2.59
107.66
7.49
7.04
Div. Payout %
0%
0%
0%
0%
0%
0%
0%
0%
0%
Not meaningful for this period: the ratio divides by a base close to zero, so it is left blank rather than shown as a very large number.
5%
40%
—
Sales growth
35
35
13
13
18
9
0
19
−71
24
12
12
50

Balance Sheet

₹ Cr
ASTERDM balance sheet, annual, ₹ crore
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
389
403
403
505
505
497
497
500
500
500
500
518
872
Reserves
1,096
17
1,472
2,327
2,709
2,775
2,875
3,080
3,574
3,686
2,554
3,683
6,919
Borrowings
1,091
3,321
2,758
2,352
2,788
5,605
4,804
5,282
6,075
1,758
2,392
2,594
5,940
Other Liabilities
1,834
2,003
2,171
2,296
2,926
3,528
3,444
3,661
4,687
12,039
1,154
1,280
3,792
Total Liabilities
4,409
5,743
6,804
7,479
8,928
12,405
11,620
12,521
14,836
17,983
6,600
8,076
17,523
Fixed Assets
2,237
2,507
3,520
3,738
4,289
7,124
6,749
7,009
9,052
3,175
3,920
4,242
12,205
CWIP
197
358
290
402
550
736
934
998
279
170
293
420
529
Investments
3
39
32
38
22
34
63
45
80
17
245
1,167
422
Other Assets
1,972
2,839
2,962
3,302
4,067
4,511
3,874
4,470
5,425
14,620
2,142
2,248
4,366
Total Assets
4,409
5,743
6,804
7,479
8,928
12,405
11,620
12,521
14,836
17,983
6,600
8,076
17,523

Cash Flow

₹ Cr
ASTERDM cash flow, annual, ₹ crore
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
236
203
361
537
601
1,223
1,569
1,314
1,834
158
425
656
Investing
−439
−775
−1,136
−522
−702
−658
−333
−563
−951
−878
6,015
−288
Financing
203
578
654
46
134
−675
−1,116
−686
−817
1,053
−6,358
−304
Net Cash Flow
−1
5
−122
61
33
−110
120
65
66
332
82
63
Free Cash Flow
−176
−536
−565
23
64
715
1,183
770
995
−601
70
179
CFO/EBITDA
51
53
116
93
61
88
143
89
424
40
71
93

Ratios

ASTERDM financial ratios, annual
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
83
93
79
84
93
100
86
72
285
23
23
24
Inventory Days
93
92
102
111
110
138
122
129
612
44
36
32
Days Payable
178
187
151
150
153
303
290
267
1,400
183
166
168
Cash Conversion Cycle
−2
−1
30
45
50
−65
−83
−66
−503
−116
−107
−112
Working Capital Days
69
68
6
59
28
8
5
5
−21
272
−32
−28
ROCE %
14%
6%
1%
7%
13%
12%
6%
10%
3%
4%
11%
12%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Aster DM Healthcare insights

68 extracted metrics across FY14–FY27.

Shareholding Pattern

As of Sep 2026

  • Promoters 53.79%
  • DIIs 21.67%
  • FIIs 12.26%
  • Others 7.79%
  • Public 4.49%

66.85% of promoter holding pledged as of Sep 2026

Change since Jun 2026

Not shown for some quarters: Others. Not available separately for this quarter: the shareholding filing gives Public and Others as one figure, shown under Public, so Others is left blank rather than estimated.

Documents

Frequently Asked Questions about Aster DM Healthcare

What does Aster DM Quality Care Ltd do?
Aster DM Healthcare Limited is one of the largest integrated private healthcare service providers operating in GCC (Gulf Cooperation Council) countries and an emerging player in India.
Where is Aster DM Quality Care Ltd (ASTERDM) listed?
Aster DM Quality Care Ltd trades as ASTERDM on the NSE and under code 540975 on the BSE.
Which sector does Aster DM Quality Care Ltd belong to?
Aster DM Quality Care Ltd is classified under the Healthcare sector, in the Healthcare Services industry.
What is the market capitalisation of Aster DM Quality Care Ltd?
Aster DM Quality Care Ltd has a market capitalisation of ₹67,929 Cr as of 20 Nov 2026, which places it in the Midcap band.
What is the PE ratio of Aster DM Quality Care Ltd?
Aster DM Quality Care Ltd trades at a PE ratio of 110.70 as of 20 Nov 2026, on earnings per share of ₹7.04, against a book value of ₹89.38 per share.
What is the 52-week high and low of Aster DM Quality Care Ltd?
Over the last 52 weeks Aster DM Quality Care Ltd has traded between ₹519.1 and ₹891.3 as of 20 Nov 2026.
Does Aster DM Quality Care Ltd pay dividends?
Aster DM Quality Care Ltd has a dividend yield of 0.41%.
What is the Return on Equity (ROE) of Aster DM Quality Care Ltd?
Aster DM Quality Care Ltd reported a return on equity of 11.30%. Its debt-to-equity ratio is 0.76.

Company Information

Aster DM Healthcare Limited is one of the largest integrated private healthcare service providers operating in GCC (Gulf Cooperation Council) countries and an emerging player in India. With an inherent emphasis on clinical excellence, it is one of the few entities in the world with a strong presence across primary, secondary, tertiary and quaternary healthcare.

CEO Dr. Mandayapurath Azad Moopen DTCD, M.D., MBBS
Employees 15,334
Listed 26 Feb 2018
Face Value ₹10
Shares Outstanding 87,16,72,439

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/ASTERDM.md for Aster DM Quality Care Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More